Genetic backgrounds of asthma and COPD

Allergology International

Volumn 58, Issue 3, 2009, Pages 315-322

  Hizawa, Nobuyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

ADAM33; Asthma; CCL5; COPD; Dutch hypothesis; IL17F

Indexed keywords

ADAM PROTEIN; CD14 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPEPTIDYL CARBOXYPEPTIDASE; EOTAXIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; NITRIC OXIDE SYNTHASE; RANTES; SERINE PROTEINASE INHIBITOR; STAT6 PROTEIN; SUPEROXIDE DISMUTASE; THROMBOXANE A2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; LINKAGE ANALYSIS; LUNG PARENCHYMA; MOLECULAR GENETICS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INJURY; TISSUE REPAIR;

EID: 70450162973     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.09-RAI-0105     Document Type: Review

References (55)

1. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008;8:183-192. (Pubitemid 351323287)
2. Gelb AF, Zamel N, Krishnan A. Physiologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008;14:24-30. (Pubitemid 350191035)
3. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 2008;8:169-182. (Pubitemid 351323288)
4. Orie NGM, van der Lende R (eds). Bronchitis III: Third International Symposium on Bronchitis. Assen, the Netherlands: Royal van Gorcum, 1970;115.
5. A plea to abandon asthma as a disease concept. Lancet 2006;368:705.
6. Allen M, Heinzmann A, Noguchi E et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet 2003;35:258-263 (Pubitemid 37363180)
7. Laitinen T, Polvi A, Rydman P et al. Characterization of a common susceptibility locus for asthma-related traits. Science 2004;304:300-304 (Pubitemid 38452184)
8. Moffatt MF, Kabesch M, Liang L et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007;448:470-473 (Pubitemid 47123521)
9. Bouzigon E, Corda E, Aschard H et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med 2008;359:1985-1994.
10. Hirota T, Harada M, Sakashita M et al. Genetic polymorphism regulating ORM1-like 3 (Saccharomyces cerevisiae) expression is associated with childhood atopic asthma in a Japanese population. J Allergy Clin Immunol 2008;121:769-770.
11. Bisgaard H, Bønnelykke K, Sleiman PM et al. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am J Respir Crit Care Med 2009;179:179-185.
12. Laurell CB, Eriksson S. The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-140.
13. Beck GJ, Doyle CA, Schachter EN. Smoking and lung function. Am Rev Respir Dis 1981;123:149-155.
14. Bentley AR, Emrani P, Cassano PA. Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review. Thorax 2008;63:956-961.
15. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med 2008;178:906-912.
16. Silverman EK, Mosley JD, Palmer LJ et al. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum Mol Genet 2002;11:623-632. (Pubitemid 34285133)
17. Silverman EK, Palmer LJ, Mosley JD et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J HumGenet 2002;70:1229-1239. (Pubitemid 34450572)
18. Palmer LJ, Celedo'n JC, Chapman HA, Speizer FE, Weiss ST, Silverman EK. Genome-wide linkage analysis of bronchodilator responsiveness and post- bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet 2003;12:1199-1210.
19. DeMeo DL, Mariani TJ, Lange C et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J HumGenet 2006;78:253-264. (Pubitemid 43157565)
20. Hahn DL. Beyond the Dutch hypothesis. Am J Respir Crit Care Med 2006;174:1056.
21. Orie NGM, Sluiter HJ, De Vries K, Tammeling GJ, Witkop J. The host factor in bronchitis. In: Orie NGM, Sluiter HJ (eds). Bronchitis. Assen, the Netherlands: Royal Van Gorcum, 1961;43-59.
22. Brutsche MH, Downs SH, Schindler C et al., for the SAPALDIA Team. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006;61:671-677. (Pubitemid 44211773)
23. Kim EY, Battaile JT, Patel AC et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008;14:633-640.
24. Borchers MT, Wesselkamper SC, Curull V et al. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest 2009;119:636-649.
25. Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002;418:426-430. (Pubitemid 34826843)
26. Blakey J, Halapi E, Bjornsdottir US et al. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax 2005;60:274-276. (Pubitemid 40522361)
27. Holgate ST, Davies DE, Powell RM, Howarth PH, Haitchi HM, Holloway JW. Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. Eur Respir J 2007;29:793-803.
28. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005;172: 329-333. (Pubitemid 41026143)
29. Gosman MM, Boezen HM, van Diemen CC et al. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 2007;62:242-247. (Pubitemid 46579805)
30. Hizawa N, Yamaguchi E, Konno S, Tanino Y, Jinushi E, Nishimura M. A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Respir Crit Care Med 2002;166:686-690. (Pubitemid 34971851)
31. Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 2002;110:165-175. (Pubitemid 34787353)
32. Holgate ST. Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target. J Allergy Clin Immunol 2006;118:587-590.
33. Contoli M, Message SD, Laza-Stanca V et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006;12:1023-1026. (Pubitemid 44353382)
34. Seemungal T, Harper-Owen R, Bhowmik A et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-1623. (Pubitemid 33124148)
35. Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:871-876.
36. Retamales I, Elliott WM, Meshi B et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001;164:469-473. (Pubitemid 32778218)
37. Gern JE, French DA, Grindle KA, Brockman-Schneider RA, Konno S, Busse WW. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithe lial cells. Am J Respir Cell Mol Biol 2003;28:731-737. (Pubitemid 36677177)
38. Saito T, Deskin RW, Casola A et al. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 1997;175:497-504. (Pubitemid 27086151)
39. Zhu J, Qiu YS, Majumdar S et al. Exacerbations of bronchitis. Bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med 2001;164:109-116. (Pubitemid 33151307)
40. Matsukura S, Kokubu F, Kubo H et al. Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol 1998;18:255-264. (Pubitemid 128355199)
41. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:115-120.
42. Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653. (Pubitemid 38787999)
43. Hizawa N, Makita H, Nasuhara Y et al., for Hokkaido COPD Cohort Study Group. Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients. Eur Respir J 2008;32:372-378.
44. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD. Available at: http://www.goldcopd.com/Guideline.
45. Patel BD, Coxson HO, Pillai SG et al., for International COPD Genetics Network. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:500-505.
46. Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 2005;171:12-18. (Pubitemid 40051689)
47. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma clinical and biologic significance. Am J Respir Crit Care Med 2000;161:1185-1190.
48. O'byrne PM, Postma DS. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med 1999;159:S41-63.
49. Little SA, MacLeod KJ, Chalmers GW, Love JG, McSharry C, Thomson NC. Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med 2002;112:446-452 (Pubitemid 34450704)
50. Lamblin C, Gosset P, Tillie-Leblond I et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998;157:394-402. (Pubitemid 28090526)
51. Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033-1042
52. Kawaguchi M, Takahashi D, Hizawa N et al. Interleukin-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 2006;117:795-801.
53. Hizawa N, Kawaguchi M, Huang S-K, Nishimura M. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin Exp Allergy 2006;36:1109-1114 (Pubitemid 44342924)
54. Hashimoto K, Graham BS, Ho SB et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5 ac and gob-5. Am J Respir Crit Care Med 2004;170:306-312 (Pubitemid 38971416)
55. Kang MJ, Lee CG, Lee JY et al. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008;118:2771-2784